A Japanese health ministry proposal to impose steeper price cuts on certain medicines deemed to carry poor cost-effectiveness profiles cleared…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY 13 Generic Makers Slapped with Improvement Order due to South Korean Supplier’s GMP Violation
January 30, 2013
-
ORGANIZATION Wholesale Industry FTC Curbs Returns of Drugs to Be Discarded
January 29, 2013
-
BUSINESS Medipal Group Introduces Special Mini Cooler for New Orphan Drug
January 29, 2013
-
REGULATORY PAFSC First Committee on New Drugs to Discuss Approval of Japan’s First FD Treatment
January 28, 2013
-
BUSINESS Novartis, Sanofi Dissolve Partnership on Equa Copromotion
January 25, 2013
-
BUSINESS Transparency GL: Drug Makers Might Disclose Individual Payments Only Upon Request
January 24, 2013
-
BUSINESS Merck Serono Aims for Top 10 Slot in Oncology Field
January 23, 2013
-
BUSINESS Sanofi’s Dellegra Promotion to Home in on Stuffy Nose
January 22, 2013
-
BUSINESS Pfizer Detailing Infectious Disease Portfolios across Divisions
January 21, 2013
-
BUSINESS Drug Makers’ Specialty Care Pipelines Hit Snags in Late-Stage Development
January 21, 2013
-
ORGANIZATION JPMA Bolstering ICH Activities to Propose New Topics from Industry
January 18, 2013
-
BUSINESS Celgene K.K. Focused on MR Training Aiming for No. 1 Ranking Among Hematologists in 2013
January 18, 2013
-
BUSINESS OrphanPacific’s Orphan Drug Biz Faces Rough Going with Rising Costs
January 17, 2013
-
BUSINESS Domestic Drug Makers Working to Escape Dependence on Long-Listed Drugs through New Product Development
January 17, 2013
-
BUSINESS GMP Violations at Drug Substance Makers Prompt Series of New Voluntary Recalls of Generics; Stable Supplies Disrupted
January 16, 2013
-
ORGANIZATION JMA Vice Pres. Nakagawa Urges Pharmacies to Rigidly Check Medical Exam History of Epadel OTC Buyers
January 15, 2013
-
REGULATORY Focus May Be on Whether New Price Cutting Rule for Long-Listed Drugs Should Apply Only to Those Granted Premium
January 15, 2013
-
REGULATORY PMDA Probes How Insurance Pharmacies Utilize Drug Safety Information
January 11, 2013
-
BUSINESS Takeda to Pitch Lotriga for Patients with Residual Event Risks, Cultivate New Market
January 10, 2013
-
BUSINESS AbbVie to Focus on Specialty Care, “Not Interested” in Established Markets: CEO Winer
January 9, 2013
ページ
A Japanese drug pricing panel on November 11 discussed ways to respond to the US most-favored-nation (MFN) policy, with healthcare…
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Japan is set to add 16 new drugs to its NHI reimbursement price list on November 13, including a subcutaneous…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…